CAP TODAY/Genentech Webinar: PD-L1 Testing in Metastatic Triple Negative Breast Cancer: Challenging Cases To Help Update Your Practice

Thank you

This live web event has ended. Thank you for attending.

Description

PD-L1 Testing in Metastatic
Triple Negative Breast Cancer:
Challenging Cases To Help Update Your Practice

Why should you register now for this webinar?
Hear national thought leaders discuss PD-L1 testing in TNBC
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenters: Ashley Cimino-Mathews, MD and Leisha A. Emens, MD, PhD

What will this webinar empower you to do?
Comprehend the challenges in PD-L1 testing in TNBC today
Gain insight into the optimal interchange between pathologists and oncologists
Understand the importance of PD-L1 testing in TNBC now and into the future
Ask questions of our distinguished presenters

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a promotional sponsorship from Genentech.

Contributors

Bob McGonnagle

Publisher, CAP TODAY
Ashley Cimino-Mathews, MD

Associate Professor of Pathology and Oncology
Director of the Breast Pathology Program
The Johns Hopkins Hospital
Baltimore, Maryland
Leisha A. Emens, MD, PhD

UPMC Hillman Cancer Center/Magee Women's
Hospital Director of Translational Immunotherapy
for the Women's Cancer Research Center
Co-Leader, Hillman Cancer Immunology/
Immunotherapy Program
Pittsburgh, Pennsylvania